Showing results (31-40 of 1,308) with videos related to
Sort By:
Pageof 131
European Heart Journal|June 1, 2007
A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failureAli Ahmed, Faiez Zannad, Thomas E Love, et al.European Journal of Heart Failure|April 8, 2014
Effect of eplerenone in percutaneous coronary intervention-treated post-myocardial infarction patients with left ventricular systolic dysfunction: a subanalysis of the EPHESUS trialJavaid Iqbal, Renaud Fay, David Adlam, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 7, 2021
Estimated plasma volume status in heart failure: clinical implications and future directionsMasatake Kobayashi, Nicolas Girerd, Kevin Duarte, et al.European Journal of Heart Failure|October 31, 2009
Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trialChris Adamopoulos, Ali Ahmed, Renaud Fay, et al.The American Journal of Cardiology|July 17, 2007
Effects of valsartan alone versus valsartan/simvastatin combination on ambulatory blood pressure, C-reactive protein, lipoproteins, and monocyte chemoattractant protein-1 in patients with hyperlipidemia and hypertensionSanjay Rajagopalan, Faiez Zannad, Anca Radauceanu, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 10, 2021
Weight changes in heart failure with preserved ejection fraction: findings from TOPCATJoão Pedro Ferreira, Patrick Rossignol, Brian L Claggett, et al.Journal of Hypertension|April 24, 2018
Visit-to-visit blood pressure variation is associated with outcomes in a U-shaped fashion in patients with myocardial infarction complicated with systolic dysfunction and/or heart failure: findings from the EPHESUS and OPTIMAAL trialsJoão Pedro Ferreira, Kévin Duarte, Bertram Pitt, et al.European Heart Journal|July 7, 2007
Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approvalJeffrey S Borer, Hubert Pouleur, Eric Abadie, et al.Circulation. Heart Failure|May 10, 2014
Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonistOrly Vardeny, Brian Claggett, Inder Anand, et al.Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|April 15, 2009
Implications of the ADVANCE study for clinical practiceFaiez ZannadPageof 131